Half of Hospitalized COVID-19 Patients Develop a Complication
Study is most comprehensive of its kind and included more than 70,000 adults in the UK hospitalized with severe COVID-19 disease. Of these, half (36,367…
The Lancet
COVID Variant B117 Is More Transmissible, but Does Not Increase Severity of Symptoms
An observational study of patients in London hospitals suggests that the B.1.1.7. variant is not associated with more severe illness and death, but appears to…
Phase III Clinical Trial Success: Oxford COVID-19 Vaccine Is Safe and Protects Against Disease
First full results from interim analysis confirm that the Oxford COVID-19 vaccine (AZD1222) has an acceptable safety profile and is efficacious against symptomatic COVID-19 disease,…
Chinese COVID-19 Vaccine Phase 2 Trial Results: Safe and Induces an Immune Response
Phase 2 randomized controlled trial of a recombinant adenovirus type-5-vectored COVID-19 vaccine (Ad5-vectored COVID-19 vaccine) was conducted in China in April 2020 and involved more…
Most Comprehensive Study to Date: Optimal Physical Distancing, Face Masks, and Eye Protection to Prevent Spread of COVID-19
First review of all available evidence including 172 observational studies looking at how physical distancing, face masks, and eye protection affect the spread of COVID-19,…
Large Observational Study: No Evidence of Benefit for Chloroquine or Hydroxychloroquine in COVID-19 Patients
Retraction: This article has been retracted by 3 of its 4 authors after they were unable to independently verify their data. A large observational study…
New Triple Antiviral Drug Combination Shows Promise for Treating COVID-19
First evidence that early treatment with triple antiviral therapy of interferon beta-1b, lopinavir-ritonavir, and ribavirin — alongside standard care — is safe and shortens duration…